{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:04:43Z","timestamp":1792789483204,"version":"4.5.0"},"reference-count":42,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NeurolMed Biopharma in collaboration with Corestem Chemon Co., Ltd.","award":["22-ME-0967N"],"award-info":[{"award-number":["22-ME-0967N"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Memory impairment is a defining characteristic of Alzheimer\u2019s disease (AD), with amnesia often appearing as its earliest symptom. Given the multifactorial nature of AD pathogenesis, this study investigates the multi-target therapeutic potential of sobrerol (coded as NRM-331) in a scopolamine-induced amnesia mouse model, focusing specifically on its effects in ameliorating memory deficits and enhancing neuronal plasticity. Sixty male C57BL\/6NCrljOri mice were divided into six groups (10 mice\/group): vehicle control (CTL, saline), scopolamine (SPA, 10 mg\/kg\/day), Aricept (APT, 2 mg\/kg\/day), and three treatment groups receiving NRM-331 at doses of 40, 80, and 100 mg\/kg\/day. Several behavioral tests were conducted, including the Y-maze test, passive avoidance test, and Morris water maze test. Additionally, biochemical assays were performed in serum (to measure A\u00df 1-40 and A\u00df 1-42) and in the brain (to assess ACh and AChE levels), along with histopathological examination of the brain using Nissl staining and p-tau IHC. No significant change was observed in the Y-maze test or the acquisition trial of the passive avoidance test. However, improvements were noted in the retention trial of the passive avoidance test and the Morris water maze test (including escape latency, swim distance, and number of platform crossed) for the NRM-331 groups compared to the SPA group. Serum levels of A\u00df 1-40 and A\u00df 1-42 decreased in the NRM-331 groups compared to the SPA group. In the brain, levels of ACh significantly increased, while AChE levels significantly decreased compared to the SPA group. The number of neuronal cells improved in the CA1, CA3, and DG regions of the hippocampus, as indicated by Nissl staining. A significant reduction in p-tau accumulation was also observed in the NRM-331 groups. In conclusion, NRM-331 demonstrated an anti-amnesic effect by enhancing hippocampal cholinergic signaling, alongside exhibiting anti-tau and anti-A\u03b2 synthesis properties. These therapeutic effects suggest that NRM-331 significantly mitigates memory impairment induced by SPA through a neuroprotective mechanism.<\/jats:p>","DOI":"10.3390\/ijms26104613","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T10:58:07Z","timestamp":1747047487000},"page":"4613","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sobrerol Improves Memory Impairment in the Scopolamine-Induced Amnesia Mouse Model"],"prefix":"10.3390","volume":"26","author":[{"given":"AbuZar","family":"Ansari","sequence":"first","affiliation":[{"name":"NeurolMed, Room 302, 91, Changryongdae-ro 256 beon-gil, Yeongtong-gu, Suwon-si 16229, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geon-Seok","family":"Park","sequence":"additional","affiliation":[{"name":"NeurolMed, Room 302, 91, Changryongdae-ro 256 beon-gil, Yeongtong-gu, Suwon-si 16229, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-9652","authenticated-orcid":false,"given":"Soo-Jeong","family":"Park","sequence":"additional","affiliation":[{"name":"NeurolMed, Room 302, 91, Changryongdae-ro 256 beon-gil, Yeongtong-gu, Suwon-si 16229, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-Ra","family":"Goh","sequence":"additional","affiliation":[{"name":"NeurolMed, Room 302, 91, Changryongdae-ro 256 beon-gil, Yeongtong-gu, Suwon-si 16229, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Hoon","family":"Je","sequence":"additional","affiliation":[{"name":"NeurolMed, Room 302, 91, Changryongdae-ro 256 beon-gil, Yeongtong-gu, Suwon-si 16229, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1037\/0735-7044.101.3.347","article-title":"Memory dysfunction and word priming in dementia and amnesia","volume":"101","author":"Shimamura","year":"1987","journal-title":"Behav. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1037\/0033-295X.99.2.195","article-title":"Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans","volume":"99","author":"Squire","year":"1992","journal-title":"Psychol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1098\/rstb.1997.0148","article-title":"Amnesia, memory and brain systems","volume":"352","author":"Nervous","year":"1997","journal-title":"Philos. Trans. R. Soc. London. Ser. B Biol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"ref_5","first-page":"639","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","article-title":"Immune modulation of learning, memory, neural plasticity and neurogenesis","volume":"25","author":"Yirmiya","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1212\/01.CON.0000466656.59413.29","article-title":"Memory dysfunction","volume":"21","author":"Matthews","year":"2015","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bbr.2010.11.037","article-title":"The cholinergic system and hippocampal plasticity","volume":"221","author":"Drever","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1152\/jn.1992.67.5.1230","article-title":"Cholinergic modulation of cortical associative memory function","volume":"67","author":"Hasselmo","year":"1992","journal-title":"J. Neurophysiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejphar.2010.09.001","article-title":"Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice","volume":"649","author":"Kwon","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bajo, R., Pusil, S., Lopez, M.E., Canuet, L., Pereda, E., Osipova, D., Maest\u00fa, F., and Pekkonen, E. (2015). Scopolamine effects on functional brain connectivity: A pharmacological model of Alzheimer\u2019s disease. Sci. Rep., 5.","DOI":"10.1038\/srep09748"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sohn, E., Lim, H.S., Kim, Y.J., Kim, B.Y., Kim, J.H., and Jeong, S.J. (2019). Elaeagnus glabra f. oxyphylla attenuates scopolamine-induced learning and memory impairments in mice by improving cholinergic transmission via activation of CREB\/NGF signaling. Nutrients, 11.","DOI":"10.3390\/nu11061205"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1248\/bpb.29.71","article-title":"Acteoside of Callicarpa dichotoma attenuates scopolamine-induced memory impairments","volume":"29","author":"Lee","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.lfs.2007.02.023","article-title":"Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory disruption in mice","volume":"80","author":"Kim","year":"2007","journal-title":"Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jep.2012.12.047","article-title":"Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice","volume":"146","author":"Kim","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11064-009-0051-4","article-title":"Scopolamine induced amnesia is reversed by Bacopa monniera through participation of kinase-CREB pathway","volume":"35","author":"Saraf","year":"2010","journal-title":"Neurochem. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000194928","article-title":"Effect of long-term treatment with sobrerol on the exacerbations of chronic bronchitis","volume":"50","author":"Castigiioni","year":"1986","journal-title":"Respiration"},{"key":"ref_19","first-page":"381","article-title":"Review on sobrerol as a muco-modifying drug: Experimental data and clinical findings in hypersecretory bronchopulmonary diseases","volume":"7","author":"Braga","year":"1987","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.2147\/IJGM.S497547","article-title":"Sobrerol in Managing Acute Respiratory Infections in Clinical Practice During the \u201cCold\u201d Season: An Italian Primary Care Experience","volume":"17","author":"Varricchio","year":"2024","journal-title":"Int. J. Gen. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ciprandi, G., and Varriccchio, A. (2023). Sobrerol: New perspectives to manage patients with frequent respiratory infections. Children, 10.","DOI":"10.20944\/preprints202306.2165.v1"},{"key":"ref_22","first-page":"105","article-title":"Action of sobrerol on mucociliary transport","volume":"42","author":"Allegra","year":"1981","journal-title":"Children"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lu, C.H., Huang, Y.F., and Chu, I.M. (2022). Design of Oral Sustained-Release Pellets by Modeling and Simulation Approach to Improve Compliance for Repurposing Sobrerol. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010167"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: A crucial factor in Alzheimer\u2019s disease","volume":"24","author":"Sabermarouf","year":"2015","journal-title":"Med. Princ. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0962-8924(98)01368-3","article-title":"Tau in Alzheimer\u2019s disease","volume":"8","author":"Mandelkow","year":"1998","journal-title":"Trends Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.2004.01848.x","article-title":"The safety and tolerability of donepezil in patients with Alzheimer\u2019s disease","volume":"58","author":"Jackson","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1471-4159.2009.06562.x","article-title":"Naturally occurring phytochemicals for the prevention of Alzheimer\u2019s disease","volume":"112","author":"Kim","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/0253-7613.56072","article-title":"Cholinergic influence on memory stages: A study on scopolamine amnesic mice","volume":"41","author":"Agrawal","year":"2009","journal-title":"Indian J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2009.06.012","article-title":"Scopolamine-induced deficits in social memory in mice: Reversal by donepezil","volume":"204","author":"Riedel","year":"2009","journal-title":"Behav. Brain Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"More, S.V., Kumar, H., Cho, D.Y., Yun, Y.S., and Choi, D.K. (2016). Toxin-induced experimental models of learning and memory impairment. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091447"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00212843","article-title":"Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist \u03b2-carbolines","volume":"94","author":"Sarter","year":"1988","journal-title":"Psychopharmacology"},{"key":"ref_32","first-page":"960","article-title":"Passive avoidance","volume":"2","author":"Stiedl","year":"2010","journal-title":"Encycl. Psychopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"104363","DOI":"10.1016\/j.phrs.2019.104363","article-title":"The complexities of behavioural assessment in neurodegenerative disorders: A focus on Alzheimer\u2019s disease","volume":"147","author":"Commins","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: Procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Baek, S.Y., Li, F.Y., Kim, D.H., Kim, S.J., and Kim, M.R. (2020). Enteromorpha prolifera extract improves memory in scopolamine-treated mice via downregulating amyloid-\u03b2 expression and upregulating BDNF\/TrkB pathway. Antioxidants, 9.","DOI":"10.3390\/antiox9070620"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4926815","DOI":"10.1155\/2017\/4926815","article-title":"Amelioration of scopolamine-induced learning and memory impairment by \u03b1-pinene in C57BL\/6 mice","volume":"2017","author":"Lee","year":"2017","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00001199-200501000-00008","article-title":"Update of neuropathology and neurological recovery after traumatic brain injury","volume":"20","author":"Povlishock","year":"2005","journal-title":"J. Head Trauma Rehabil."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Schraen-Maschke, S., Duhamel, A., Vidal, J.S., Ramdane, N., Vaudran, L., Dussart, C., Bu\u00e9e, L., Sablonni\u00e8re, B., Delaby, C., and Allinquant, B. (2024). The free plasma amyloid A\u03b21\u201342\/A\u03b21\u201340 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma A\u03b21\u201342\/A\u03b21\u201340 ratio. The BALTAZAR study. Neurobiol. Dis., 193.","DOI":"10.1016\/j.nbd.2024.106459"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbr.2012.10.016","article-title":"Decreased acetylcholine release delays the consolidation of object recognition memory","volume":"238","author":"Cammarota","year":"2013","journal-title":"Behav. Brain Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Squire, L.R., Shimamura, A.P., and Amaral, D.G. (1989). Memory and the hippocampus. Neural Models of Plasticity, Elsevier.","DOI":"10.1016\/B978-0-12-148956-4.50016-4"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.12688\/f1000research.13737.1","article-title":"Classic and recent advances in understanding amnesia","volume":"7","author":"Allen","year":"2018","journal-title":"F1000Research"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4613\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:31:05Z","timestamp":1760031065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104613"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104613","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}